Proof of principle for bevacizumab activity in desmoid-type fibromatosis.

Viktor GruenwaldFlorian LängerH J RaatschenAndreas Beilken

Published in: Clinical sarcoma research (2016)

This is the first report on single agent bevacizumab in DF, which showed both, good tolerability and efficacy in our patient, thereby warranting future trials in DF.

Keyphrases

metastatic colorectal cancer
open label
current status
double blind
placebo controlled